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Letters to the Editorseen in a subgroup of patients with ag-
gressive coronary atherosclerosis.
Conversely, the pathophysiologic re-
sponse5 to the presence of an intravas-
cular foreign body (stent) may also
adversely affect the fate of the conduits
used to graft stented coronary arteries.
Stenting can cause prolonged endothe-
lial dysfunction, as well as an acute
and chronic inflammatory reaction,
even during the late period, with in-
volvement of the distal coronary artery
and surrounding myocardium.5 This
may adversely affect anastomosis sites
in patients who subsequently undergo
coronary artery bypass grafting.
A vexed question is whether the
poor fate of venous conduits used to
bypass coronary arteries with in-stent
restenosis is due to aggressive athero-
sclerosis or to an inflammatory reac-
tion involving downstream coronary
artery beds. Although we do not
know the distribution of occluded con-
duits with respect to stent locations,
we cannot definitively point out the
influences on graft patency. We there-
fore do not support inclusion of these
data in meta-analyses.
Dusko Nezic, MD, PhD, FETCS
Aleksandar Knezevic, MD, BcS
Petar Vukovic, MD, BcS
‘‘Dedinje’’ Cardiovascular Institute
Belgrade, Serbia
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We thank Nezic and colleagues for
their interest in our recent article.1 We
regret to point out, however, that
Nezic and colleagues misrepresent
data reported by Gaudino and associ-
ates.2 In fact, 2 different analyses
were reported in that study. First, Gau-
dino and associates2 reported an an-
giographic comparison of radial
artery (RA) and saphenous vein graft
(SVG) conduits randomly assigned
to target obtuse marginal coronary ar-
teries (OMs) with previous stenting
(study group) versus OMs without
previous (control group). The results
of this comparison were shown in
Gaudino and associates’ Table 3,2
which compared 20 RA conduits
versus 20 SVG conduits from the
study group and 20 RA conduits ver-
sus 20 SVG conduits from the control
group. In addition, they reported an-
giographic results of other conduits
not randomly assigned to complete re-
vascularization in both the study and
control groups (see Gaudino and asso-
ciates’ Table 22).
For the purpose of ourmeta-analysis
of randomized, controlled trials, we in-
cluded only conduits randomly as-
signed to target OMs. Therefore, in
our study the Gaudino I study included
RA versus SVG conduits randomly
grafted to previously stented OMs,
and the Gaudino II study included
RA versus SVG conduits grafted to un-
stented OMs. The risk that intrastent
restenosis would influence the results
was exactly the same for all RA and
SVG conduits used in the first cohort
of patients (Gaudino I). Nezic and
colleagues picked up data referring
to conduits not randomly assigned to
complete revascularization (see Gau-
dino and associates’ Table 2), thus
completely misrepresenting the inclu-
sion criteria adopted in our meta-
analysis of randomized, controlled
trials.
Umberto Benedetto, MD
Emiliano Angeloni, MDof Thoracic and Cardiovascular SurgerRiccardo Sinatra, MD
Cardiac Surgery Department
University of Rome ‘‘La Sapienza’’
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To the Editor:
The meta-analytical review by
Benedetto and colleagues1 comparing
failure rates of radial artery (RA) and
saphenous vein (SV) conduits in coro-
nary artery bypass grafting has several
methodologic flaws that significantly
limit its validity. Consequently, we
strongly believe that both the data pre-
sented and the conclusion that ‘‘no
definitive evidence supports the superi-
ority of the RA over the SV in terms of
graft failure rate’’1 cannot be accepted
without challenge.
Benedetto and colleagues’ restrictive
inclusion criteria1 may have excluded
data from several high-quality studies
that considered different target lesions
or used definitions of graft failure other
than total graft occlusion or severe dif-
fuse graft narrowing (string sign).1 An-
giographic stenosis of more than 50%,
70%, or 75%, for example, may cause
symptomatic ischemia and may require
repeated angiography. Finally, Bene-
detto and colleagues1 appear to have ex-
cluded important studies in which
assessment of angiographic patency
was performed at a fixed interval as a
secondary end point. These restrictive
inclusion criteria compromise they c Volume 139, Number 6 1669
Letters to the Editorgeneralizability of the study. More im-
portantly, however, they prevent full
consideration of all relevant available
evidence. A PubMed search reveals 6
randomized, controlled trials compar-
ing the patency of RA and SV conduits,
but only 5 (or more accurately 4 sepa-
rate article) were included in this study.
Furthermore, no justification was given
for ignoring the 36 nonrandomized
studies that have compared many thou-
sands of angiograms. Because all rele-
vant studies were not included, several
clinically important variables were not
examined, such as long-term (>5 years)
conduit patency, which is a more rele-
vant end point when selecting revascu-
larization strategy than is the 22-
month mean angiographic follow-up
reported.1
Closer inspection of the extracted
data, discussion, and study methodol-
ogy reveals several critical flaws that
compromise the study findings. The
correct observational long-term pa-
tency data of the RAPCO (Radial
Artery Patency and Clinical Outcome)
trial can be found in a later article
authored by Hayward and associates2
(angiographic follow-up time 60
months, RA patency 89.1%, SV pa-
tency 82.4%), but Benedetto and
colleagues1 selected an earlier report,
possibly because they focused on fail-
ure rate rather than patency. Metare-
gression of only 5 studies is flawed
for several statistical reasons.3 Bene-
detto and colleagues1 have concluded
on the basis of results with unknown
heterogeneity that patency is compara-
ble between RA and SV conduits and
that the time of follow-up does not
affect the accuracy of the overall esti-
mate of patency. These conclusions
are not possible unless early, midterm,
and long-term patencies have been
examined in a stratified manner,
because different mechanisms are
responsible for graft failure at different
time horizons. Other sources of hetero-
geneity, for example the quality of
reporting of the angiographic patency,
do not appear to have been investi-
gated. Although the authors stated1670 The Journal of Thoracic andthat I2 was calculated, this value was
not reported.
The flawed methodology, results,
and conclusions of this study have in-
troduced an even more distorted view
of the existing evidence. Benedetto
and colleagues assessed the literature
through a key hole and consequently
cannot see the evidence horizon. This
perspective misinforms clinical deci-
sion making and misguides the focus
of future research. This article is an
example of fast-track publication of
a poorly conducted meta-analysis
without consideration of the potential
causes of heterogeneity and without
taking into account characteristics of
angiographic patency that justify its
use as a surrogate outcome.
Thanos Athanasiou, MD, PhD,
FETCSa
Christopher Rao, MRCS, BSca
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doi:10.1016/j.jtcvs.2009.12.049Reply to the Editor:
We would like to underline some
fundamental issues concerning meta-
analyses that Athanasiou and col-
leagues seem to have forgotten in their
letter.Cardiovascular Surgery c June 2010First, in cardiac surgery, as in other
clinical fields, conclusive evidence
should be addressed by the analysis
of randomized, controlled trials
(RCTs) when available. Observational
studies frequently reach distorted con-
clusions because they are influenced
by confounding. For example, no
RCT has ever confirmed the benefits
of beating-heart coronary surgery
implied by observational studies.1
In addition, graft failure is an out-
come strongly influenced by the qual-
ity of target vessels.2 It is reasonable
to suppose that in clinical practice, ra-
dial artery conduits have been used for
good quality target vessels, whereas
saphenous vein grafts have been used
on poorer quality vessels to complete
revascularization. This concern in
observational cohorts may not confi-
dently be controlled for by any risk
adjusted-analysis but is completely
eliminated by randomization. There-
fore for this topic, RCTs, even with
their limitations, are largely better
than any observational cohort study.
Even a keyhole is preferable to a black
hole. There is thus no reason to con-
duct a meta-analysis on observational
distorted results when several RCTs
are fortunately available. Despite these
considerations, Athanasiou and col-
leagues love to read and publish
meta-analyses of nonrandomized com-
parative studies, even when a large
body of RCTs is available. They there-
fore reach conclusions3 completely
discordant with RCTs,4 and it is hard
to justify the exceptions made for se-
lection bias related to nonrandomized
design.
Second, the Editor of this Journal is
interested in brief contributions. As
stated in the Information for Authors,
brief communications provide an op-
tion to have an article published in
a more rapid fashion. Therefore our
work is not an example of fast-track
publication but rather is in line with
the policy of this Journal. As Athana-
siou and colleagues can see, several
meta-analyses of RCTs on different
topics in cardiac surgery are published
